You just read:

Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating Defibrotide for the Potential Prevention of VOD in High Risk Patients

News provided by

Jazz Pharmaceuticals plc

Jan 17, 2017, 16:02 ET